Summary of Prognostic Factors and Patient Selection for Extrapleural Pneumonectomy in the Treatment of Malignant Pleural Mesothelioma
- 22 April 2011
- journal article
- review article
- Published by Springer Science and Business Media LLC in Annals of Surgical Oncology
- Vol. 18 (10), 2973-2979
- https://doi.org/10.1245/s10434-011-1728-x
Abstract
Extrapleural pneumonectomy (EPP) has been shown to improve long-term survival outcomes in selected patients with malignant pleural mesothelioma (MPM). The present study aimed to evaluate potential prognostic factors on overall survival for patients who underwent EPP for MPM and to examine the patient selection process in major referral centers that perform EPP.A systematic review of the current literature was performed using 5 electronic databases. Relevant studies with prognostic data on overall survival for patients with MPM treated by EPP were included for review. Two reviewers independently assessed each included study.A total of 17 studies from 13 institutions containing the most updated and complete data on prognostic factors for patients with MPM who underwent EPP were included for review. A number of quantitative, clinical, and treatment-related factors were identified to have significant impact on overall survival.Patients with nonepithelial MPM and nodal involvement have consistently demonstrated to have a worse prognosis after EPP. Their eligibility as candidates for EPP should be questioned. The preoperative patient selection process currently differs greatly between institutions and should focus on identifying patients with nonepithelial histologic subtypes and nodal involvement to exclude them as EPP surgical candidates in the future.Keywords
This publication has 30 references indexed in Scilit:
- Characteristics of Malignant Pleural Mesothelioma in WomenThe Annals of Thoracic Surgery, 2010
- Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: A phase II prospective studyThe Journal of Thoracic and Cardiovascular Surgery, 2009
- Multicenter Phase II Trial of Neoadjuvant Pemetrexed Plus Cisplatin Followed by Extrapleural Pneumonectomy and Radiation for Malignant Pleural MesotheliomaJournal of Clinical Oncology, 2009
- A phase I study of extrapleural pneumonectomy and intracavitary intraoperative hyperthermic cisplatin with amifostine cytoprotection for malignant pleural mesotheliomaThe Journal of Thoracic and Cardiovascular Surgery, 2009
- Mesothelioma: Benefit from Surgical Resection is QuestionableJournal of Thoracic Oncology, 2007
- Ten traps for the unwary in surgical series: A case study in mesothelioma reportsThe Journal of Thoracic and Cardiovascular Surgery, 2007
- A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesotheliomaThe Journal of Thoracic and Cardiovascular Surgery, 2001
- The European mesothelioma epidemicBritish Journal of Cancer, 1999
- Analysis of Current Trends in United States Mesothelioma IncidenceAmerican Journal of Epidemiology, 1997
- Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients.Thorax, 1976